Strategic AI Integration in Marketing Outpaces Speed, ONAR Holding Corp. Leads the Shift
The marketing landscape is undergoing a significant transformation, with strategic consistency and AI integration becoming the cornerstone of sustainable growth. ONAR Holding Corp. (ONAR) is at the forefront of this shift, advocating for a move away from the traditional ‘move fast and break things’ approach to a more measured, data-driven strategy. The company’s proprietary AI platform, Cortex, is instrumental in driving results across various marketing domains, including integrated performance media, SEO, and industry-specialized marketing.
Recent industry studies, including a 2024 McKinsey study, underscore the efficacy of this approach, revealing that companies embedding AI into their marketing operations experience revenue growth two to three times faster than those relying on isolated tactics. This data highlights the diminishing returns of speed-focused campaigns in the face of evolving customer journeys and the increasing complexity of digital marketing ecosystems.
ONAR’s network of technology-first agencies is pioneering this strategic pivot, focusing on long-term results over flashy, reactive campaigns. By leveraging Cortex, ONAR is able to connect data, technology, and creativity in a measurable way, setting a new standard for marketing effectiveness. The implications of this shift are profound, suggesting a future where strategic depth and AI integration become the primary drivers of marketing success, rather than the speed of campaign deployment.
For more information on ONAR’s innovative approach to marketing, visit https://ibn.fm/ONAR.
This news story relied on content distributed by None. Blockchain Registration, Verification & Enhancement provided by NewsRamp
. The source URL for this press release is Strategic AI Integration in Marketing Outpaces Speed, ONAR Holding Corp. Leads the Shift.
More From Montreal Breaking
Sleep Tourism Market is to grow at a...
The Sleep Tourism Market (BPO) will reach USD 142.22 Billion by 2032. The Sleep Tourism...
Lantern Pharma Inc.’s AI-Driven Drug LP-300 Shows Promise...
The recent Phase 2 HARMONIC(TM) trial conducted by Lantern Pharma Inc. has brought to light...
Foremost Clean Energy Ltd. Advances Uranium Exploration with...
Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) has taken a significant step forward in...
Nobel Laureate Prof. J. Michael Kosterlitz Reflects on...
The discovery of the Kosterlitz-Thouless (KT) transition by Prof. J. Michael Kosterlitz and David Thouless...